Exponent, Inc.

Valuation Analysis

About the Company

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering. The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and he

Exponent, Inc. Stock at a Glance

Exponent, Inc. (EXPO) is currently trading at $57.08 with a market capitalization of $2.8B. The trailing P/E ratio stands at 26.67x, with a forward P/E of 20.68x. The 52-week range spans from $51.91 to $81.95; the current price is 30.3% below the yearly high. Year-over-year revenue growth stands at +10.5%. The net profit margin stands at 19.76%.

💰 Dividend

Exponent, Inc. pays an annual dividend of $1.22 per share, representing a yield of 2.14%. The payout ratio stands at 56.54%.

📊 Analyst Rating

3 analysts rate Exponent, Inc. (EXPO) on consensus: None. The average price target is $81.67, implying +43.07% from the current price. Analyst price targets range from $75.00 to $90.00.

Exponent, Inc.: The Investment Case in Detail

Exponent, Inc. (EXPO) operates in the Industrials — specifically Engineering & Construction — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 10.5% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Return on equity of 27.94% places management among the most capital-efficient operators in the public market — every euro of shareholder capital is working hard. Free cash flow is positive and net margins stand at 19.76%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

What to Watch Next

• The forward P/E of 20.68x is meaningfully below the trailing 26.67x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 43.07% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (5.6%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Exponent, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.